Lassina Traore, Minane Nafissa Triande, Sidnooma Véronique Zongo, Abdoul Karim Ouattara, Mousso Savadogo, Nouhoun Nignan, Marie Simone Traore, Tegwindé Rébéca Compaore, Denise P Ilboudo, Tani Sagna, Ina Marie Traore, Birama Diarra, Albert Théophane Yonli, Bolni Marius Nagalo, Augustin Tozoula Bambara, Roger Arsène Sombie, Florencia Wendkuuni Djigma, Jacques Simpore
{"title":"非洲人群中细胞外基质蛋白1 (ECM1)基因多态性(rs3834087和rs3754217)与乙型肝炎病毒进化的关系","authors":"Lassina Traore, Minane Nafissa Triande, Sidnooma Véronique Zongo, Abdoul Karim Ouattara, Mousso Savadogo, Nouhoun Nignan, Marie Simone Traore, Tegwindé Rébéca Compaore, Denise P Ilboudo, Tani Sagna, Ina Marie Traore, Birama Diarra, Albert Théophane Yonli, Bolni Marius Nagalo, Augustin Tozoula Bambara, Roger Arsène Sombie, Florencia Wendkuuni Djigma, Jacques Simpore","doi":"10.14715/cmb/2024.70.12.5","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatitis B virus (HBV) is a significant cause of liver disease and cancer worldwide. Understanding the genetic factors influencing HBV evolution is crucial for developing effective prevention and treatment strategies. Host genetic and environmental factors particularly influence the evolution of this infection. Recent studies have implicated the ECM1 gene in HBV pathogenesis, mainly two specific polymorphisms (rs3834087 and rs3754217). In an African cohort, we comprehensively analyzed these ECM1 gene polymorphisms and their association with HBV evolution.In this case-control analysis, 167 samples, consisting of 59 controls and 108 cases, were examined. The cases included 50 patients with Chronic Hepatitis B(CHB), 16 with cirrhosis, and 42 with hepatocellular carcinoma (HCC). Genomic DNA extraction was executed using INVITROGEN and FAVORGEN kits. Genotyping of rs3834087 and rs3754217 polymorphisms in the ECM1 gene was accomplished via real-time PCR on the QuantStudioTM 5 Real-Time instrument, followed by allelic discrimination using TaqMan Genotyper Software. Data was interpreted using SPSS version 20 and Epi info version 7.5.2.0. Odds ratios (OR), confidence intervals (CI), and p-values were derived for risk and significance evaluation.In our study, the heterozygous genotype (GT) of rs3754217 could confer protection to controls against the onset of chronic hepatitis in the event of infection (OR=0.05; CI=0.006-0.46; p=0.002). In addition, carriage of mutated alleles of the two (2) polymorphisms was associated with the course of infection and may influence the appearance of severe forms at certain stages of the disease.Our study is the first to assess the association between polymorphisms (rs3834087 and rs3754217) in the ECM1 gene and the course of HBV infection in Burkina Faso. It showed that combining specific genotypes of the two (2) polymorphisms would be associated with protection against chronic hepatitis.</p>","PeriodicalId":9802,"journal":{"name":"Cellular and molecular biology","volume":"70 12","pages":"36-44"},"PeriodicalIF":1.5000,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association between extracellular matrix protein 1 (ECM1) gene polymorphisms (rs3834087 and rs3754217) and Hepatitis B Virus evolution in an African cohort.\",\"authors\":\"Lassina Traore, Minane Nafissa Triande, Sidnooma Véronique Zongo, Abdoul Karim Ouattara, Mousso Savadogo, Nouhoun Nignan, Marie Simone Traore, Tegwindé Rébéca Compaore, Denise P Ilboudo, Tani Sagna, Ina Marie Traore, Birama Diarra, Albert Théophane Yonli, Bolni Marius Nagalo, Augustin Tozoula Bambara, Roger Arsène Sombie, Florencia Wendkuuni Djigma, Jacques Simpore\",\"doi\":\"10.14715/cmb/2024.70.12.5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hepatitis B virus (HBV) is a significant cause of liver disease and cancer worldwide. Understanding the genetic factors influencing HBV evolution is crucial for developing effective prevention and treatment strategies. Host genetic and environmental factors particularly influence the evolution of this infection. Recent studies have implicated the ECM1 gene in HBV pathogenesis, mainly two specific polymorphisms (rs3834087 and rs3754217). In an African cohort, we comprehensively analyzed these ECM1 gene polymorphisms and their association with HBV evolution.In this case-control analysis, 167 samples, consisting of 59 controls and 108 cases, were examined. The cases included 50 patients with Chronic Hepatitis B(CHB), 16 with cirrhosis, and 42 with hepatocellular carcinoma (HCC). Genomic DNA extraction was executed using INVITROGEN and FAVORGEN kits. Genotyping of rs3834087 and rs3754217 polymorphisms in the ECM1 gene was accomplished via real-time PCR on the QuantStudioTM 5 Real-Time instrument, followed by allelic discrimination using TaqMan Genotyper Software. Data was interpreted using SPSS version 20 and Epi info version 7.5.2.0. Odds ratios (OR), confidence intervals (CI), and p-values were derived for risk and significance evaluation.In our study, the heterozygous genotype (GT) of rs3754217 could confer protection to controls against the onset of chronic hepatitis in the event of infection (OR=0.05; CI=0.006-0.46; p=0.002). In addition, carriage of mutated alleles of the two (2) polymorphisms was associated with the course of infection and may influence the appearance of severe forms at certain stages of the disease.Our study is the first to assess the association between polymorphisms (rs3834087 and rs3754217) in the ECM1 gene and the course of HBV infection in Burkina Faso. It showed that combining specific genotypes of the two (2) polymorphisms would be associated with protection against chronic hepatitis.</p>\",\"PeriodicalId\":9802,\"journal\":{\"name\":\"Cellular and molecular biology\",\"volume\":\"70 12\",\"pages\":\"36-44\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cellular and molecular biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.14715/cmb/2024.70.12.5\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and molecular biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.14715/cmb/2024.70.12.5","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
乙型肝炎病毒(HBV)是世界范围内肝脏疾病和癌症的重要原因。了解影响HBV进化的遗传因素对于制定有效的预防和治疗策略至关重要。宿主遗传和环境因素特别影响这种感染的演变。最近的研究表明ECM1基因与HBV的发病机制有关,主要是两种特异性多态性(rs3834087和rs3754217)。在一个非洲队列中,我们全面分析了这些ECM1基因多态性及其与HBV进化的关系。在本病例-对照分析中,共检查了167份样本,包括59份对照和108例病例。这些病例包括50例慢性乙型肝炎(CHB), 16例肝硬化,42例肝细胞癌(HCC)。使用INVITROGEN和FAVORGEN试剂盒进行基因组DNA提取。在QuantStudioTM 5实时荧光定量PCR仪上对ECM1基因rs3834087和rs3754217多态性进行基因分型,然后使用TaqMan基因分型软件进行等位基因鉴定。数据分析采用SPSS version 20和Epi info version 7.5.2.0。比值比(OR)、置信区间(CI)和p值用于风险和显著性评估。在我们的研究中,rs3754217的杂合基因型(GT)可以在感染的情况下保护对照者免受慢性肝炎的发作(OR=0.05;CI = 0.006 - -0.46;p = 0.002)。此外,携带两(2)个多态性的突变等位基因与感染过程有关,并可能影响疾病某些阶段严重形式的出现。我们的研究首次评估了布基纳法索ECM1基因多态性(rs3834087和rs3754217)与HBV感染过程之间的关系。结果表明,结合两(2)个多态性的特定基因型可能与慢性肝炎的保护有关。
Association between extracellular matrix protein 1 (ECM1) gene polymorphisms (rs3834087 and rs3754217) and Hepatitis B Virus evolution in an African cohort.
Hepatitis B virus (HBV) is a significant cause of liver disease and cancer worldwide. Understanding the genetic factors influencing HBV evolution is crucial for developing effective prevention and treatment strategies. Host genetic and environmental factors particularly influence the evolution of this infection. Recent studies have implicated the ECM1 gene in HBV pathogenesis, mainly two specific polymorphisms (rs3834087 and rs3754217). In an African cohort, we comprehensively analyzed these ECM1 gene polymorphisms and their association with HBV evolution.In this case-control analysis, 167 samples, consisting of 59 controls and 108 cases, were examined. The cases included 50 patients with Chronic Hepatitis B(CHB), 16 with cirrhosis, and 42 with hepatocellular carcinoma (HCC). Genomic DNA extraction was executed using INVITROGEN and FAVORGEN kits. Genotyping of rs3834087 and rs3754217 polymorphisms in the ECM1 gene was accomplished via real-time PCR on the QuantStudioTM 5 Real-Time instrument, followed by allelic discrimination using TaqMan Genotyper Software. Data was interpreted using SPSS version 20 and Epi info version 7.5.2.0. Odds ratios (OR), confidence intervals (CI), and p-values were derived for risk and significance evaluation.In our study, the heterozygous genotype (GT) of rs3754217 could confer protection to controls against the onset of chronic hepatitis in the event of infection (OR=0.05; CI=0.006-0.46; p=0.002). In addition, carriage of mutated alleles of the two (2) polymorphisms was associated with the course of infection and may influence the appearance of severe forms at certain stages of the disease.Our study is the first to assess the association between polymorphisms (rs3834087 and rs3754217) in the ECM1 gene and the course of HBV infection in Burkina Faso. It showed that combining specific genotypes of the two (2) polymorphisms would be associated with protection against chronic hepatitis.
期刊介绍:
Cellular and Molecular Biology publishes original articles, reviews, short communications, methods, meta-analysis notes, letters to editor and comments in the interdisciplinary science of Cellular and Molecular Biology linking and integrating molecular biology, biophysics, biochemistry, enzymology, physiology and biotechnology in a dynamic cell and tissue biology environment, applied to human, animals, plants tissues as well to microbial and viral cells. The journal Cellular and Molecular Biology is therefore open to intense interdisciplinary exchanges in medical, dental, veterinary, pharmacological, botanical and biological researches for the demonstration of these multiple links.